NCT06544057 Real-time eCounselling for Nicotine Addiction
| NCT ID | NCT06544057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Overcome |
| Condition | Nicotine Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-07-08 |
| Primary Completion | 2025-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-07-08 with a primary completion date of 2025-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to pilot an eHealth intervention (real-time telecounselling) in nicotine addiction. The main questions it aims to answer are: Is the intervention likely to be efficacious in preventing an increase in Abstinence? Is the intervention likely to be efficacious in preventing an increase in nicotine consumption? Is the intervention likely to be efficacious in influencing Readiness to quit nicotine? How feasible is the intervention for developing a larger-scale trial? Researchers will compare a range of outcome measures between the active and control arms, to see if a pilot eHealth intervention can successfully treat nicotine addiction.
Eligibility Criteria
Inclusion Criteria: 1. Age: 18-65 Years old 2. Self Reported smoking ≥ 5 cigarettes per day, or regular vaper of \> 0mg nicotine 3. Desire to quit nicotine consumption 4. Willing to set a quit date 5. Able to provide written informed consent to participate - Exclusion Criteria: 1. Enrolled in another behavioural intervention programme 2. Pregnant, breastfeeding or planning to become pregnant. 3. Individuals currently experiencing a problematic relationship with alcohol or drugs 4. Documented Cognitive Impairment 5. Individuals with a PHQ-9 score of ≥ 14 or a GAD-7 score of \>12.
Contact & Investigator
Helen Hayward, BSc
STUDY DIRECTOR
Overcome
Frequently Asked Questions
Who can join the NCT06544057 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Nicotine Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06544057 currently recruiting?
Yes, NCT06544057 is actively recruiting participants. Contact the research team at operations_manager@overcome.org.uk for enrollment information.
Where is the NCT06544057 trial being conducted?
This trial is being conducted at Leicester, United Kingdom.
Who is sponsoring the NCT06544057 clinical trial?
NCT06544057 is sponsored by Overcome. The principal investigator is Helen Hayward, BSc at Overcome. The trial plans to enroll 60 participants.